Eric Marandett Discusses the Impact of Secondary Patents in Biologics and Pharmaceutical Patent Litigation

Eric Marandett is speaking on the Consero IP Forum for Life Sciences panel “Impact of Secondary Patents in Biologics and Pharmaceutical Patent Litigation” on Monday, December 6 at 1:00 pm EST. The panel will analyze how litigants should assess the likelihood of success on validity regarding patent eligibility of secondary patents, as well as considerations in-house and outside counsel should take. Representatives from Editas Medicine and Omega Therapeutics will also speak on the panel.